Kolexia
Rossignol Michel
Cardiologie
N/A
Lieu inconnu
24 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Syndrome coronarien aigu Infarctus du myocarde Infarctus Sclérose en plaques Hypertension artérielle Purpura thrombopénique idiopathique Maladies auto-immunes Maladies du tissu conjonctif Tumeurs du sein

Industries

Bayer
1 collaboration(s)
Dernière en 2016
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Adherence To Treatment And Modifiable Risk Factors In Acute Coronary Syndrome (Acs) Patients Registered In The Pgrx Real World Datasets
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research   01 novembre 2016
Model Observational Bridging Study on the Effectiveness of Ezetimibe on Cardiovascular Outcomes
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research   01 mai 2016
Health-Related Quality of Life of Patients Suffering an Acute Coronary Syndrome: An Analysis Using Multinational Eq-5d Outcomes from the Pgrx-3 Real-World Dataset
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research   01 mai 2016
Reported Psychological Symptoms and Quality of Life in Patients Suffering an Acute Coronary Syndrome: New Insights from the Pgrx-3 Real-World Dataset
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research   01 mai 2016
Antiepileptic Drugs, Risk of Suicide Attempts, and the Impact of Underlying Medical Conditions: Results from the Pgrx Information System
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research   01 mai 2016
How Good Are Physicians And Chart Reviews At Capturing Health Resources And Drug Utilisation By Patients? Results Of The Pgrx-3 Prospective Real World Dataset Validation Study
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research   01 novembre 2015
The Quality Of Life In Patients 12 Months After An Acute Coronary Syndrom: Results From The Pgrx-3 Real World Dataset
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research   01 novembre 2015
Conditions Of Validity Of Medical Records For Drug Exposure Assessment In Pharmacoepidemiological Research
ISPOR 19th Annual International Meeting Research Abstracts   01 mai 2014
Evolution of disease outcomes in schizophrenia: Results from the “cohort for the general study of schizophrenia (CGS)” with 3 years of follow-up
ISPOR 19th Annual International Meeting Research Abstracts   01 mai 2014
Benefits of a patient-assisted medication adherence program for long-acting injectable risperidone on high-cost outcomes in schizophrenia
ISPOR 19th Annual International Meeting Research Abstracts   01 mai 2014